At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Efficacy of Seventh Generation Bonding Agents as Short-Term Desensitizers Among Patients With Hypersensitivity A Randomized Clinical Trial
In Brief
A Phase 3 clinical trial evaluating Single Bond Universal, Bifluorid 12, and 1 other intervention for Dentin Hypersensitivity. Completed, enrolled 105 participants across 1 site.
Detailed Summary
The world lacks a gold standard treatment for treating dentin hypersensitivity. Fluoride varnish is most commonly used as a treatment but it causes temporary discoloration of tooth structure and may cause irritation or burning of gums when it comes in contact with gums. Seventh generation bonding agents are less technique sensitive and are easy to use. The present study aims to find out the better seventh generation bonding agent as a treatment option for sensitivity. A total of 105 patients with dentin hypersensitivity are randomized into three groups. Scaling and root debridement are performed for all the groups. This study compares two seventh generation bonding agents and taking fluoride varnish as control group.
Study Details
Timeline
Interventions
Single bond universal (by 3M ESPE) is a seventh generation bonding agents used as desensitizers in the present study.
it is a fluoride varnish by VOCO.
Xeno V+ (by Dentsply) is a seventh generation bonding agents used as desensitizers in the present study.